Discovery of a Proteolysis-Targeting Chimera Degrader of JAK2 As a Potential Therapeutic Agent for JAK2-Mediated Myeloproliferative Neoplasms.
Journal of medicinal chemistry(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined